Biomarkers of Hemodynamic Severity of Systemic-Sclerosis Associated Pulmonary Arterial Hypertension by Serum Proteome Analysis Sebastien Sanges, MD – Medecine Interne CHRU Lille
3:10 PM – 3:20 PM ET
Pulmonary Cytokine, Chemokine and Growth Factor Profiles of Distinct Radiographic Patterns of Interstitial Lung Disease in Systemic Sclerosis Elizabeth Volkmann, MD – University of California, Los Angeles
3:20 PM – 3:30 PM ET
Interstitial Lung Disease, Kidney Inflammation and Myositis Are Induced by Transfer of PBMC Derived from Systemic Sclerosis Patients into Rag2-/-/ IL2rg-/- mice Gabriela Riemekasten, MD – University Hospital Schleswig-Holstein
3:30 PM – 3:40 PM ET
Intergenic HLA Variants in African American Patients with Systemic Sclerosis Regulate Expression of HLA-DRB1 Urvashi Kaundal, PhD – National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
3:40 PM – 3:50 PM ET
Single Cell Analysis of Skin and Blood of Scleroderma Patients Towards Identification of New Disease Mechanisms, Prognostic Biomarkers and Potential Therapeutic Targets Chamutal Gur, MD, PhD – Hadassah Medical Center
